Food and drug administration (FDA)
Ended Awarded Last action
- Contract number
- 75F40121F19176
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $32,554
Award facts
- Contract value 12% obligated
- $278,809.40 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$64,730 | |
| Exercise an Option | $121,848 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $124,408 | |
| Original award | $97,284 |
About this award
The Food and Drug Administration's Center for Food Safety and Applied Nutrition awarded a Blanket Purchase Agreement (BPA) to Brillient Corporation on July 14, 2021, with a ceiling value of $278,809.40. This competitive 8(a) set-aside contract supports the Office of Food Additive Safety (OFAS) by providing professional and technical services related to food ingredient and packaging matters. The contract operates under a labor-hours pricing model and is performed in Reston, Virginia, with an ultimate completion date of July 14, 2024. As a minority-owned Subchapter S Corporation, Brillient Corporation qualified for the 8(a) small business set-aside designation.
Brillient Corporation brings extensive federal contracting experience to this engagement, with a demonstrated track record across multiple agencies including the Department of Health and Human Services, Department of Homeland Security, and the National Institutes of Health. The company maintains significant indefinite delivery contracts, including a $55.3 million Treasury Internal Revenue Service agreement and a $58.5 million National Institutes of Health contract, along with a position on the General Services Administration's One Acquisition Solution for Integrated Services (OASIS) vehicle. Through this FDA BPA, Brillient will leverage its capabilities in program management, technical services, and consulting to support OFAS operations and food safety regulatory functions.
Quick answers
Who was awarded contract 75F40121F19176?
75F40121F19176 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on July 14, 2021.
How much is contract 75F40121F19176 worth?
The government has obligated $32,554 on 75F40121F19176. Its current value, with exercised options, is $278,809.
Is contract 75F40121F19176 an order under another contract?
Yes. 75F40121F19176 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40121F19176 competed?
The extent of competition for 75F40121F19176 was full and open competition. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award